長虹佳華(03991.HK)上半年純利1.75億港元 同比下降5.46%
格隆匯8月10日丨長虹佳華(03991.HK)發佈公吿,2022年上半年,集團實現收益約179.06億港元,較上財年同期下降19.65%;今年上半年整體毛利率3.09%,較上財年同期上升約0.46個百分點;股東應占溢利錄得約1.75億港元,較上財年同期下降約5.46%,基本每股盈利約為6.82港仙,較上財年同期的7.21港仙約下降0.39港仙。
2022年下半年,集團繼續以“新認知、新動能、智慧好夥伴”為經營方針,把握數字經濟發展新趨勢,在雲、網、數、智、虛擬現實等數字產業重點領域聚焦深化,探索新模式,發展新動能,持續推進戰略轉型升級,為股東不斷創造價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.